Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuriy Fedorov

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
RNA (New York, N.Y.)|April 14, 2006
Induction of the interferon response by siRNA is cell type- and duplex length-dependentAngela Reynolds, Emily M Anderson, Annaleen Vermeulen, et al.
Plos One|August 21, 2012
Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysisChad M Thompson, Yuriy Fedorov, Daniel D Brown, et al.
Nature Communications|July 16, 2025
Elaboration of molecular glues that target TRIM21 into TRIMTACs that degrade protein aggregatesMarc A Scemama de Gialluly, Anthony R Allen, Elijah H Hayes, et al.
International Journal of Biological Macromolecules|June 12, 2023
Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complicationsMukesh Kumar, Robert J Gaivin, Shenaz Khan, et al.
Nature Methods|February 21, 2006
3' UTR seed matches, but not overall identity, are associated with RNAi off-targetsAmanda Birmingham, Emily M Anderson, Angela Reynolds, et al.
Nature Neuroscience|March 26, 2024
Pervasive environmental chemicals impair oligodendrocyte developmentErin F Cohn, Benjamin L L Clayton, Mayur Madhavan, et al.
Stem Cell Reports|January 11, 2019
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting DrugsAnil Belur Nagaraj, Peronne Joseph, Erin Ponting, et al.
The Journal of Clinical Investigation|September 10, 2019
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcomaIan Bayles, Malgorzata Krajewska, W Dean Pontius, et al.
Progress in Biophysics and Molecular Biology|March 6, 2021
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformationMy T Nguyen, Davide Moiani, Zamal Ahmed, et al.
Nature Chemical Biology|March 26, 2024
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activationYi Fan Chen, Maryam Ghazala, Ryan M Friedrich, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
RNA (New York, N.Y.)|April 14, 2006
Induction of the interferon response by siRNA is cell type- and duplex length-dependentAngela Reynolds, Emily M Anderson, Annaleen Vermeulen, et al.
Plos One|August 21, 2012
Assessment of Cr(VI)-induced cytotoxicity and genotoxicity using high content analysisChad M Thompson, Yuriy Fedorov, Daniel D Brown, et al.
Nature Communications|July 16, 2025
Elaboration of molecular glues that target TRIM21 into TRIMTACs that degrade protein aggregatesMarc A Scemama de Gialluly, Anthony R Allen, Elijah H Hayes, et al.
International Journal of Biological Macromolecules|June 12, 2023
Definition of fatty acid transport protein-2 (FATP2) structure facilitates identification of small molecule inhibitors for the treatment of diabetic complicationsMukesh Kumar, Robert J Gaivin, Shenaz Khan, et al.
Nature Methods|February 21, 2006
3' UTR seed matches, but not overall identity, are associated with RNAi off-targetsAmanda Birmingham, Emily M Anderson, Angela Reynolds, et al.
Nature Neuroscience|March 26, 2024
Pervasive environmental chemicals impair oligodendrocyte developmentErin F Cohn, Benjamin L L Clayton, Mayur Madhavan, et al.
Stem Cell Reports|January 11, 2019
A miRNA-Mediated Approach to Dissect the Complexity of Tumor-Initiating Cell Function and Identify miRNA-Targeting DrugsAnil Belur Nagaraj, Peronne Joseph, Erin Ponting, et al.
The Journal of Clinical Investigation|September 10, 2019
Ex vivo screen identifies CDK12 as a metastatic vulnerability in osteosarcomaIan Bayles, Malgorzata Krajewska, W Dean Pontius, et al.
Progress in Biophysics and Molecular Biology|March 6, 2021
An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformationMy T Nguyen, Davide Moiani, Zamal Ahmed, et al.
Nature Chemical Biology|March 26, 2024
Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activationYi Fan Chen, Maryam Ghazala, Ryan M Friedrich, et al.
Pageof 3